Pharmaceutical

ILution travoprost by Glaukos for Open-Angle Glaucoma: Likelihood of Approval

ILution travoprost is under clinical development by Glaukos and currently in Phase II for Open-Angle Glaucoma.

Jun 20, 2024 - 04:00
ILution travoprost by Glaukos for Open-Angle Glaucoma: Likelihood of Approval
ILution travoprost is under clinical development by Glaukos and currently in Phase II for Open-Angle Glaucoma.
Read the original article

Tags:

Previous Article

Large wildfires create weather that favors more fire

Next Article

ILution travoprost by Glaukos for Ocular Hypertension: Likelihood of Approval

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

The U.S. hasn’t seen syphilis numbers this high since 1950. Other STD rates are down or flat

The U.S. hasn’t seen syphilis numbers this high since 1...

Jan 30, 2024

Merck is on the lookout for more opportunities within immunology

Merck is on the lookout for more opportunities within i...

Jan 29, 2024

STAT+: A lawsuit over a controversial Sanofi drug shortage is unexpectedly revived

STAT+: A lawsuit over a controversial Sanofi drug short...

Feb 21, 2024